Image Quality: Ultra-Low Dose Scanner Versus Standard Dose Conventional Scanner for Thoraco-abdominopelvic Scans (UL2DLR)
Imaging, Diagnostic, Lung Diseases, Abdomen Disease
About this trial
This is an interventional diagnostic trial for Imaging, Diagnostic
Eligibility Criteria
Inclusion Criteria: Patient having given free and informed consent. Patient who has signed the consent form. Patient affiliated to or beneficiary of a health insurance plan. Patient with a BMI < 35 kg/m2 Exclusion Criteria: Patient participating in research involving human subjects defined as Category 1. Patient in an exclusion period as determined by another study. Patient under court protection, guardianship or trusteeship. Patient unable to give consent. Patient for whom it is impossible to give informed information. Pregnant patient. Patient with a BMI ≥ 35 kg/m2
Sites / Locations
Arms of the Study
Arm 1
Experimental
Patients undergoing Ultra-Low-Dose scan plus conventional standard dose thoraco-abdominopelvic scan
All adult patients (except pregnant women) presenting to the imaging department of the Institut de Cancérologie du Gard for a thoraco-abdominopelvic scan as part of an oncology follow-up will under a standard-dose can as well as an ultra-low-dose scan.